Understanding the Proteomic and Physiological Effects of Impella and ECMO Devices
JSHS · 2022
Overview
Heart failure occurs when the heart is unable to function efficiently—often caused by the development of an infarct, or an area of dead heart tissue. The extremity of infarct formation correlates with heart failure severity, and patients are often placed on ECMO/impella devices to assess the state of the patient for surgery. However, 50% of patients with these devices die due to complications that result from unknown causes. Additionally, there is no accessible way to predict infarct size and thus evaluate the severity of the disease. Research evaluating whether ecpella (bailout and preemptive) devices influence infarct size is needed. Furthermore, the hemodynamic effects of ecpella are poorly understood. As a result, the goals of this project are to identify biomarkers and signaling pathways involved in impella and ECMO implantation using a proteomic platform as well as use tools in machine learning to identify determinants of infarct size based on hemodynamic data and interpretability. More specifically, we used Ingenuity Pathway Analysis (IPA) to evaluate proteomic differences as well as pathways, diseases, and tox functionalities involved in post vs pre impella, post vs pre ECMO, and post impella vs post ECMO groups. Using hemodynamic reperfusion data of preemptive and bailout samples, Knearest neighbors, Xgboost, and regression models (linear, polynomial, lasso, and ridge) were used to predict infarct size. Five algorithms (the regression models and Xgboost) achieved low error rates as well as high R2 values in terms of predicting infarct size. Through interpretability and analyzing data distribution, it was found that the preemptive ecpella group provided better cardiovascular health compared to the bailout group. Thus, this research helps improve the understanding of the proteomic effects of ECMO and impella as well as the hemodynamic differences.
Competition history
- JSHS 2022
Resources
Related projects
ISEF · 2026
Liposomal Encapsulation to Reduce Propofol Adsorption in Extracorporeal Membrane Oxygenation (ECMO) Systems
ISEF · 2024
Continuous Hemodynamics Monitor: Novel Smart Sensor for Real-Time Postoperative Cardiac Care
ISEF · 2015
Characterization of Vascular Responses to Mechanically Induced Continuous Flow Patterns in Bovine Models
ISEF · 2019
Engineering a Novel Wearable Biosensing Mechanism through the Implementation of Microelectromechanical Systems and Machine Learning to Realize Anomalies Hinting towards Future Cardiac Episodes
ISEF · 2025
Novel Fusion Protein Approach to Cardiovascular Disease With Computational Modelling
ISEF · 2017
Developing Novel Gene Candidates (MEF2A, LTA, LGALS2, ALOX5AP, and PDE4D), through an Adaptive Genetic Algorithm, Support Vector Cluster, and Dynamic Bayesian Networks, to Analyze in a Learning Classifier System for a Highly Propitious CRISPR Therapy for Ischemic Heart Disease
ISEF · 2020
Determining Gene Interactions in Congenital Heart Disease for Development of a Comprehensive Fetal Cardiac Diagnostics Platform
ISEF · 2020
Cardiomyopathic Chagas Disease: An Exploration of Diagnostic Ability via Nanoparticle Biomarker Capture GluOx Pathway, Mass Spectrometry, and Perseus-Based Machine Learning
Closest projects by meaning, across every fair and year in the corpus.